Major Exercise Alert: Richard Buchholz Exercises Options Worth $722K At Inspire Medical Systems - Inspire Medical Systems ( NYSE:INSP )
Richard Buchholz, Chief Financial Officer at Inspire Medical Systems INSP, reported a large exercise of company stock options on August 21, according to a new SEC filing. What Happened: A notable Form 4 filing on Thursday with the U.S.
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm - Anika Therapeutics ( NASDAQ:ANIK ) , Fluor ( NYSE:FLR )
NEW YORK, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutex Health Inc. NUTX, Anika Therapeutics, Inc. ANIK, Fluor Corporation FLR, and Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference - Inspire Medical Systems ( NYSE:INSP )
MINNEAPOLIS, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. to Present at the Wells Fargo 2025 Healthcare Conference
MINNEAPOLIS, Aug. 20, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. ( NYSE: INSP ) ( Inspire ) , a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that ...
Nyxoah Secures FDA Clearance for Genio System to Treat Sleep Apnea
NYXH wins FDA approval for its leadless, battery-free Genio sleep apnea therapy, backed by strong trial results.
INSPIRE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Inspire Medical Systems, Inc. on Behalf of Inspire Stockholders and Encourages Investors to Contact the Firm - Inspire Medical Systems ( NYSE:INSP )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire ( INSP ) To Contact Him Directly To Discuss Their Options
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of ...
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 - Nyxoah ( NASDAQ:NYXH )
Mont-Saint-Guibert, Belgium - August 11, 2025, 7:00am CET / 1:00am ET - Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) ( "Nyxoah" or the "Company" ) , a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea ( OSA ) , today announced certain ...
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inspire Medical Systems, Inc. - INSP - Inspire Medical Systems ( NYSE:INSP )
NEW YORK, Aug. 09, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Inspire Medical Systems, Inc. ( "Inspire" or the "Company" ) INSP. Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
INSPIRE ( INSP ) ALERT: Bragar Eagel & Squire, P.C. is Investigating Inspire Medical Systems, Inc. on Behalf of Inspire Stockholders and Encourages Investors to Contact the Firm - Inspire Medical Systems ( NYSE:INSP )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inspire ( INSP ) To Contact Him Directly To Discuss Their Options
Inspire Medical Stock Strays Off Course Amid Structural Setback - Inspire Medical Systems ( NYSE:INSP )
Inspire Medical Systems INSP iStocks currently in Phase 10 of its 18-phase cycle under the Adhishthana framework. Unfortunately for investors, the stock has broken below a key structural formation, the Cakra, which suggests a prolonged period of underperformance and potential bearishness.
Inspire Medical Systems, Inc. Investors: Company Investigated by the Portnoy Law Firm - Inspire Medical Systems ( NYSE:INSP )
Investors can contact the law firm at no cost to learn more about recovering their losses
Inspire Medical Systems Analysts Lower Their Forecasts After Q2 Results - Inspire Medical Systems ( NYSE:INSP )
Inspire Medical Systems, Inc. INSP reported second-quarter results and cut its FY25 guidance below estimates on Monday. Inspire Medical Systems reported quarterly earnings of 45 cents per share which beat the analyst consensus estimate of 21 cents per share.
Inspire Medical Plunges On Outlook Cut, Weak V System Rollout: Analysts React - Inspire Medical Systems ( NYSE:INSP )
Inspire Medical cuts FY25 EPS forecast to 40 cents-50 cents vs. consensus of $2.27. Q2 sales beat estimates at $217.09 million, but the company posts an EPS loss of 12 cents. Get special access to three exclusive "Top 10 Stocks" power lists today, updated daily. Inspire Medical Systems, Inc.
Nasdaq Down 50 Points; ISM Services PMI Declines In July - Ameresco ( NYSE:AMRC ) , Agilon Health ( NYSE:AGL )
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite falling around 50 points on Tuesday. The Dow traded up 0.12% to 44,228.65 while the NASDAQ declined 0.24% to 21,003.87. The S&P 500 also fell, dropping, 0.15% to 6,320.30. Consumer staples shares jumped by 0.4% on Tuesday.
INVESTOR ALERT: Investigation of Inspire Medical Systems, Inc. ( INSP ) Announced by Holzer & Holzer, LLC - Inspire Medical Systems ( NYSE:INSP )
ATLANTA, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Holzer & Holzer, LLC is investigating whether Inspire Medical Systems, Inc. ( "Inspire Medical" or the "Company" ) INSP complied with federal securities laws.
INSP Stock Plunges Despite Q2 Earnings Beat, Gross Margin Contracts
Inspire Medical tops second-quarter 2025 earnings estimates and posts solid revenue growth, but trims 2025 guidance amid margin pressure.
Inspire Medical Systems, Inc. Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm's Investigation - Inspire Medical Systems ( NYSE:INSP )
BOSTON, Aug. 05, 2025 ( GLOBE NEWSWIRE ) -- Block & Leviton is investigating Inspire Medical Systems, Inc. INSP for potential securities law violations. Investors who have lost money in their Inspire Medical Systems, Inc. investment should contact the firm to learn more about how they might ...
Dow Surges Over 100 Points; Pfizer Earnings Top Views - Agilon Health ( NYSE:AGL ) , Ichor Holdings ( NASDAQ:ICHR )
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.25% to 44,285.50 while the NASDAQ climbed 0.25% to 21,106.41. The S&P 500 also rose, gaining, 0.19% to 6,341.77.
This Block Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Inspire Medical Systems ( NYSE:INSP ) , International Paper ( NYSE:IP )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Keybanc analyst Brett Fishbin downgraded Inspire Medical Systems, Inc.
Inspire Medical Systems, Ichor Holdings, Vertex Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Inspire Medical Systems ( NYSE:INSP ) , Ichor Holdings ( NASDAQ:ICHR )
U.S. stock futures were higher this morning, with the Dow futures gaining around 0.1% on Tuesday. Shares of Inspire Medical Systems, Inc. INSP fell sharply in pre-market trading after the company reported second-quarter results and cut its FY25 guidance below estimates.
Inspire Medical ( INSP ) Q2 Revenue Up 11%
Inspire Medical Systems ( NYSE:INSP ) , a medical device company specializing in neurostimulation systems for obstructive sleep apnea ( OSA ) , reported its earnings for the second quarter of fiscal 2025 on August 4, 2025.
Why Palantir Technologies Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket - Agilon Health ( NYSE:AGL ) , Adaptimmune Therapeutics ( NASDAQ:ADAP )
Shares of Palantir Technologies Inc. PLTR rose sharply in pre-market trading after the company reported better-than-expected financial results for the second quarter and raised its full-year guidance. Palantir reported second-quarter revenue of $1.004 billion, beating analyst estimates of $939.71 ...
Inspire Medical Systems ( INSP ) Q2 Earnings and Revenues Surpass Estimates
Inspire (INSP) delivered earnings and revenue surprises of +104.55% and +0.95%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Butterfly Network, Inc. ( BFLY ) Reports Q2 Loss, Misses Revenue Estimates
Butterfly Network (BFLY) delivered earnings and revenue surprises of +14.29% and -2.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Doximity ( DOCS ) Reports Next Week: Wall Street Expects Earnings Growth
Doximity (DOCS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Sustained Product Demand Drive HIMS Stock Before Q2 Earnings?
Hims & Hers benefits from strong product demand and subscriber growth ahead of second-quarter 2025 earnings, fueled by weight loss and specialty care uptake.
Inspire Medical Systems ( INSP ) Expected to Beat Earnings Estimates: Should You Buy?
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential
There's a strong case that healthcare is the most important sector in the stock market. These companies deliver innovative therapies and medical technologies that are often life-saving.Investors stand to benefit as healthcare leaders and emerging players address the needs of an aging global ...
Thermo Fisher Stock Hurt by Macroeconomic Woes, Tough Competition
TMO grapples with macro pressures, rising expenses and fierce competition, but bets on acquisitions to fuel recovery.
Here's Why You Should Retain AMED Stock in Your Portfolio for Now
Amedisys' high Quality of Patient Care and Patient Satisfaction star ratings bring optimism to investors. Yet, a dull macroeconomic condition adds to the worry.
Is the Options Market Predicting a Spike in Inspire Medical Systems Stock?
Investors need to pay close attention to INSP stock based on the movements in the options market lately.
Here's Why You Should Retain PODD Stock in Your Portfolio Now
Insulet's Omnipod 5 gains traction with global expansion and rising Type 2 adoption despite economic and competitive hurdles.
Is it Apt to Retain Omnicell Stock in Your Portfolio Now?
OMCL stays on investors' radar due to its strong 2025 growth targets with automation and tech services, but faces margin risks from macro and competitive headwinds.
Here's Why You Should Retain ICLR Stock in Your Portfolio Now
Investors remain optimistic about ICON, driven by its commitment to enhance clinical delivery by integrating AI and impressive strategic pacts.
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. ( NYSE: INSP ) ( Inspire ) , a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its ...
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
MINNEAPOLIS, May 30, 2025 ( GLOBE NEWSWIRE ) -- Inspire Medical Systems, Inc. ( NYSE: INSP ) ( Inspire ) , a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its ...
Is Bio-Techne Stock the Right Pick for Your Portfolio Now?
TECH is gaining ground in cell and gene therapy, and with Ella, while navigating macro hurdles. Is it the right fit for your portfolio today?
Prestige Consumer Gains 35.7% in a Year: What's Driving the Stock?
PBH stock jumps on the back of brand strength, e-commerce gains and smart acquisitions despite tariff and foreign exchange headwinds.
Insulet Gains 78.5% in a Year: What's Driving the Stock?
PODD's shares rise on the back of Omnipod 5's growth, global expansion, and strong Q1 2025 gains despite rising operating costs and macro headwinds.
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
Investors are optimistic about HSIC, owing to the strong performance of its Henry Schein One business.
Penumbra Rallies 35.9% in a Year: What's Driving the Stock?
PEN has shown notable strength over the past year, driven by the performance of its core U.S. thrombectomy business. Solid international prospects instill optimism.
Should Tandem Diabetes Stock Stay in Your Portfolio Now?
Investors remain optimistic about TNDM, courtesy of its strong t:slim X2 performance and breakthrough innovations.
All You Need to Know About Inspire ( INSP ) Rating Upgrade to Buy
Inspire (INSP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Wall Street Analysts Predict a 39.04% Upside in Inspire ( INSP ) : Here's What You Should Know
The consensus price target hints at a 39% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
INSP Stock Gains Following Q1 Earnings Beat, Gross Margin Contracts
Inspire Medical's first-quarter 2025 performance reflects increased market penetration in existing centers and expansion into new territories and centers, along with strong domestic results.
